Aptorum Group Extends DiamiR Merger Agreement to June 2026

summarizeSummary

Aptorum Group has extended the termination date for its merger agreement with DiamiR Biosciences Corp. to June 30, 2026, indicating continued efforts to finalize the strategic transaction.

check_boxKey Events

• Merger Agreement Extended

  The termination date for the Agreement and Plan of Merger with DiamiR Biosciences Corp. has been extended from December 31, 2025, to June 30, 2026.

• Related Agreements Also Extended

  Concurrently, the Management Services Agreement and Intellectual Property License Agreement, both related to the merger, have also been extended to June 30, 2026.

• Ongoing Merger Process

  This extension confirms that Aptorum Group and DiamiR Biosciences are continuing to work towards satisfying the closing conditions for the merger, which was initially announced on July 14, 2025.

auto_awesomeAnalysis

This amendment signals continued commitment to the previously announced merger with DiamiR Biosciences. For a micro-cap company like Aptorum Group, the successful completion of this merger is a significant strategic event. The extension of the termination date from December 31, 2025, to June 30, 2026, indicates that while the process has been delayed, both parties are still actively working towards satisfying the closing conditions, preventing the deal from expiring. Investors should monitor further updates regarding the merger's progress.